🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial will evaluate the efficacy and safety of various therapies in pa...
Status
Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2020-11-06
Trial ID
NCT04302025
TAPISTRY is a Phase II, global, multicenter, open-label, multi-cohort study...
Status
Active Not Recruiting
Location
Western Regional Medical Center at Cancer Treatment Centers of America
Start Date
2021-01-18
Trial ID
NCT04589845
Circulating tumor DNA can be used to monitor the treatment effect and ident...
Status
Unknown
Location
Aarhus University Hospital
Start Date
2019-06-19
Trial ID
NCT04708639
Treatments Being Tested
This open-label, non-randomized, multicenter, Phase 1/2 study will evaluate...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2013-06-20
Trial ID
NCT01801111
The goal of this food-effect study on Alectinib pharmacokinetics is to lear...
Status
Completed
Location
Netherlands Cancer Institute
Start Date
2024-02-01
Trial ID
NCT05710133
This clinical trial aims to evaluate the efficacy, safety of ALK inhibitor ...
Status
Unknown
Location
Shanghai Changzheng Hospital
Start Date
2019-03-01
Trial ID
NCT03792568
Treatments Being Tested
The purpose of this study is to observe the clinical effect and safety of R...
Status
Unknown
Location
Multiple Locations
Start Date
2020-06
Trial ID
NCT04356118
This single center, open-label, 3-period, fixed-sequence study will evaluat...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT01940510
This study will compare the efficacy and safety of molecularly-guided thera...
Status
Completed
Location
Blacktown Hospital
Start Date
2018-07-10
Trial ID
NCT03498521
The objective of this study is to explore the safety of alectinib in combin...
Status
Completed
Location
Royal North Shore Hospital
Start Date
2024-11-18
Trial ID
NCT06624059
Treatments Being Tested